Ventricular-Vascular Interaction in Heart Failure

Barry A Borlaug, David A. Kass

Research output: Contribution to journalArticle

174 Citations (Scopus)

Abstract

Nearly half of all patients who have heart failure have preserved ejection fraction (HFpEF). Patients who have HFpEF tend to be older, female, and hypertensive, and characteristically display increased ventricular and arterial stiffening. In this article, we discuss the pathophysiology of abnormal ventriculoarterial stiffening and how it affects ventricular function, cardiovascular hemodynamics, reserve capacity, and symptoms. We conclude by exploring how novel treatment strategies targeting abnormal ventricular-arterial interaction might prove useful in the treatment of patients who have HFpEF.

Original languageEnglish (US)
Pages (from-to)23-36
Number of pages14
JournalHeart Failure Clinics
Volume4
Issue number1
DOIs
StatePublished - Jan 2008

Fingerprint

Blood Vessels
Heart Failure
Ventricular Function
Hemodynamics
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Ventricular-Vascular Interaction in Heart Failure. / Borlaug, Barry A; Kass, David A.

In: Heart Failure Clinics, Vol. 4, No. 1, 01.2008, p. 23-36.

Research output: Contribution to journalArticle

Borlaug, Barry A ; Kass, David A. / Ventricular-Vascular Interaction in Heart Failure. In: Heart Failure Clinics. 2008 ; Vol. 4, No. 1. pp. 23-36.
@article{605265eb416b4c34974bc2929721e1f5,
title = "Ventricular-Vascular Interaction in Heart Failure",
abstract = "Nearly half of all patients who have heart failure have preserved ejection fraction (HFpEF). Patients who have HFpEF tend to be older, female, and hypertensive, and characteristically display increased ventricular and arterial stiffening. In this article, we discuss the pathophysiology of abnormal ventriculoarterial stiffening and how it affects ventricular function, cardiovascular hemodynamics, reserve capacity, and symptoms. We conclude by exploring how novel treatment strategies targeting abnormal ventricular-arterial interaction might prove useful in the treatment of patients who have HFpEF.",
author = "Borlaug, {Barry A} and Kass, {David A.}",
year = "2008",
month = "1",
doi = "10.1016/j.hfc.2007.10.001",
language = "English (US)",
volume = "4",
pages = "23--36",
journal = "Heart Failure Clinics",
issn = "1551-7136",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Ventricular-Vascular Interaction in Heart Failure

AU - Borlaug, Barry A

AU - Kass, David A.

PY - 2008/1

Y1 - 2008/1

N2 - Nearly half of all patients who have heart failure have preserved ejection fraction (HFpEF). Patients who have HFpEF tend to be older, female, and hypertensive, and characteristically display increased ventricular and arterial stiffening. In this article, we discuss the pathophysiology of abnormal ventriculoarterial stiffening and how it affects ventricular function, cardiovascular hemodynamics, reserve capacity, and symptoms. We conclude by exploring how novel treatment strategies targeting abnormal ventricular-arterial interaction might prove useful in the treatment of patients who have HFpEF.

AB - Nearly half of all patients who have heart failure have preserved ejection fraction (HFpEF). Patients who have HFpEF tend to be older, female, and hypertensive, and characteristically display increased ventricular and arterial stiffening. In this article, we discuss the pathophysiology of abnormal ventriculoarterial stiffening and how it affects ventricular function, cardiovascular hemodynamics, reserve capacity, and symptoms. We conclude by exploring how novel treatment strategies targeting abnormal ventricular-arterial interaction might prove useful in the treatment of patients who have HFpEF.

UR - http://www.scopus.com/inward/record.url?scp=39649106311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39649106311&partnerID=8YFLogxK

U2 - 10.1016/j.hfc.2007.10.001

DO - 10.1016/j.hfc.2007.10.001

M3 - Article

VL - 4

SP - 23

EP - 36

JO - Heart Failure Clinics

JF - Heart Failure Clinics

SN - 1551-7136

IS - 1

ER -